"O Hospital da Luz Lisboa tem disponível: consultas, exames de diagnóstico, análises clínicas, cirurgias, internamento, atendimento urgente, maternidade, entre outros serviços médicos. Para mais informações, por favor consulte o website. Caso tenha uma consulta ou exame marcado e tem tosse, febre, dificuldade respiratória, perdeu o olfato ou o sabor, se está em confinamento, se teve contacto com um doente infetado, antes de vir ao Hospital da Luz entre em contacto com a LUZ 24 (217 104 424) - serviço gratuito de triagem clínica do Hospital da Luz para adultos e crianças, disponível 24 horas/365 dias."

During the past decade, Hospital da Luz conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 20 clinical trials were completed, i.e. on average, 37.7% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 19 clinical trials were completed. i.e. 63.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital da Luz" #1 sponsor was "Bayer" with 8 trials, followed by "Shire" with 5 trials sponsored, "Amgen" with 4 trials sponsored, "Celgene" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital da Luz" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Hospital da Luz" are "Breast Cancer" (7 trials), "Crohn's Disease" (4 trials), "Ulcerative Colitis" (4 trials), "Atrial Fibrillation" (2 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Hospital da Luz" in a lesser frequency.

Most popular intervention types in "Hospital da Luz" are "Drug" (49 trials), "Other" (8 trials), "Biological" (3 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Ontamalimab" (4 trials), "Gemcitabine" (3 trials), "Carboplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital da Luz" are 50 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital da Luz". 1 are not yet recruiting, 16 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Hospital da Luz, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital da Luz, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".

Hospital da Luz has several departments that took part in Clinical trials: "Hospital da Luz; Departamento de Oncologia Medica" - 11 trials